Literature DB >> 29297008

Preventing Lung Cancer Mortality by Computed Tomography Screening: The Effect of Risk-Based Versus U.S. Preventive Services Task Force Eligibility Criteria, 2005-2015.

Li C Cheung1, Hormuzd A Katki1, Anil K Chaturvedi1, Ahmedin Jemal2, Christine D Berg1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29297008      PMCID： PMC6785198          DOI： 10.7326/M17-2067

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  4 in total

1.  Lung Cancer Screening With Low-Dose Computed Tomography in the United States-2010 to 2015.

Authors:  Ahmedin Jemal; Stacey A Fedewa
Journal:  JAMA Oncol       Date:  2017-09-01       Impact factor: 31.777

2.  Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-year Smokers: Implications for Screening.

Authors:  Paul F Pinsky; Barnett S Kramer
Journal:  J Natl Cancer Inst       Date:  2015-10-19       Impact factor: 13.506

3.  Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.

Authors:  Hormuzd A Katki; Stephanie A Kovalchik; Christine D Berg; Li C Cheung; Anil K Chaturvedi
Journal:  JAMA       Date:  2016-06-07       Impact factor: 56.272

4.  Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391
  4 in total
  18 in total

1.  Improving CT screening for lung cancer with a highly predictive risk model.

Authors:  Cristiano Rampinelli; Marta Minotti
Journal:  Ann Transl Med       Date:  2018-04

2.  Identification of Candidates for Longer Lung Cancer Screening Intervals Following a Negative Low-Dose Computed Tomography Result.

Authors:  Hilary A Robbins; Christine D Berg; Li C Cheung; Anil K Chaturvedi; Hormuzd A Katki
Journal:  J Natl Cancer Inst       Date:  2019-09-01       Impact factor: 13.506

3.  Lung Cancer Screening Inconsistent With U.S. Preventive Services Task Force Recommendations.

Authors:  Thomas B Richards; V Paul Doria-Rose; Ashwini Soman; Carrie N Klabunde; Ralph S Caraballo; Simone C Gray; Keisha A Houston; Mary C White
Journal:  Am J Prev Med       Date:  2018-11-19       Impact factor: 5.043

4.  Identifying Patients for Whom Lung Cancer Screening Is Preference-Sensitive: A Microsimulation Study.

Authors:  Tanner J Caverly; Pianpian Cao; Rodney A Hayward; Rafael Meza
Journal:  Ann Intern Med       Date:  2018-05-29       Impact factor: 25.391

Review 5.  The importance of incorporating smoking cessation into lung cancer screening.

Authors:  Jennifer Anne Minnix; Maher Karam-Hage; Janice A Blalock; Paul M Cinciripini
Journal:  Transl Lung Cancer Res       Date:  2018-06

6.  A Task-dependent Investigation on Dose and Texture in CT Image Reconstruction.

Authors:  Yongfeng Gao; Zhengrong Liang; Hao Zhang; Jie Yang; John Ferretti; Thomas Bilfinger; Kavitha Yaddanapudi; Mark Schweitzer; Priya Bhattacharji; William Moore
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2019-12-04

7.  Effects of Personalized Risk Information on Patients Referred for Lung Cancer Screening with Low-Dose CT.

Authors:  Paul K J Han; Christine Lary; Adam Black; Caitlin Gutheil; Hayley Mandeville; Jason Yahwak; Mayuko Fukunaga
Journal:  Med Decis Making       Date:  2019-10-20       Impact factor: 2.583

8.  LDCT lung cancer screening eligibility and use of CT scans for lung cancer among sexual minorities.

Authors:  Philip Veliz; Alicia K Matthews; Cynthia Arslanian-Engoren; Rebecca J Evans-Polce; Joseph G L Lee; Carol J Boyd; Tonda Hughes; Vita V McCabe; Sean Esteban McCabe
Journal:  Cancer Epidemiol       Date:  2019-03-23       Impact factor: 2.984

9.  Prioritized concordance index for hierarchical survival outcomes.

Authors:  Li C Cheung; Qing Pan; Noorie Hyun; Hormuzd A Katki
Journal:  Stat Med       Date:  2019-04-07       Impact factor: 2.373

10.  Preempting Racial Inequities in Lung Cancer Screening.

Authors:  Jennifer Richmond; Olive M Mbah; Sofia Z Dard; Lauren C Jordan; Katherine S Cools; Cleo A Samuel; Jalaal M Khan; Matthew A Manning
Journal:  Am J Prev Med       Date:  2018-10-19       Impact factor: 5.043
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.